Analysis of The Cancer Genome Atlas (TCGA) data revealed elevated SRSF1 mRNA levels across numerous human cancer types, including those that have been largely resistant to checkpoint blockade therapies, such as melanoma and non-small cell lung cancer. This evidence concerns the gene SRSF1 and melanoma.